Clorox Is Thriving in a Post-COVID-19 World
Dividend growth investors looking for consumer staples exposure coupled with a hedge against future epidemics/pandemics might view Clorox as an excellent consideration for their portfolios. Shares yield a healthy ~2.1% at the time of this writing. By Brian Nelson, CFA On November 2, Clorox (CLX) reported stellar fiscal first-quarter earnings (period ending September 30) and raised its fiscal 2021 outlook. Revenue during the fiscal first quarter advanced 27% while diluted earnings per share more than doubled, to $3.22. Both figures came in better than expected. Fiscal 2021 revenue growth is now targeted at 5%-9% (versus guidance for a flat- to low-single digit increase previously) while diluted EPS is now expected in the range of $7.70-$7.95 for the year (versus $7.64 … Read more